Zealand Pharma — Maj 2023
-
går op og ligger mig.. -
121K omsat på 22min..
-
hod pointe, tak
-
god..
-
Zealand Pharma fremviser vægttab på op mod 14,9 pct. i fase 2-studie https://www.proinvestor.com/investornyt/982512/zealand-pharma-fremviser-vaegttab-pa-op-mod-149-pct-i-fase-2-studie
-
gisp...:)
-
fejl
-
Fra Børsen.dk "Biotekchef øjner fedmegennembrud: “Ekstremt stærke data” "..... Markedet ser noget andet end Adam S. Måske Adam skulle investere lidt i forretningen, som han tror så meget på.
-
Sydbank fik tændt pcen.. ****ZEALAND/SYDBANK: VÆGTTABSSTUDIE LEVERER GODE RESULTATER
-
****ZEALAND/SYDBANK: KAN GODT FÅ EN PLADS PÅ VOKSENDE MARKED TRODS POTENTE RIVALER
-
Fra Business.dk https://www.berlingske.dk/business/dansk-biotekfirma-faar-gode-resultater-for-mulig-wegovy-konkurrent Søren Løntoft - forventer at nå markedet 2026
-
Zealand/Sydbank: Lovende fedmedata kan give plads på attraktivt marked https://www.proinvestor.com/investornyt/982654/zealand-sydbank-lovende-fedmedata-kan-give-plads-pa-attraktivt-marked
-
Potential weight-loss drug meets goals in mid-stage trial as race accelerates
(Reuters - May 10, 2023)
-
Bemærk at Zealand Pharma storaktionær Polar Capital følger godt med. De har udtalt sig til Reuters (se Exitnu’s link): Gareth Powell, head of healthcare at Zealand shareholder Polar Capital, said participants that were not yet up to the planned maintenance dose could be included in the overall tally, potentially heralding a better weight-loss percentage.
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind